From Synapses to Behaviour: Multidimensional Translational Profiling of Hallucinogenic and Non-Hallucinogenic Neuroplastogens

9:30 am - Thursday 17th September 2026

  • Defining novel neuroplastogen signatures: AI-driven multidimensional profiling combining biomarker signatures, ultrasonic vocalisations, head-twitch response and naturalistic behaviour to identify neuroplastogen-specific phenotypes and distinguish hallucinogenic from non-hallucinogenic compounds.
  • Linking structural plasticity to functional efficacy: Integrating 3D Golgi-based neuronal morphology with synaptic and cytoskeletal biomarkers, neurophysiology and behavioural readouts to determine how structural plasticity translates into functional effects in translational models of depression.
  • Translating mechanisms across experimental systems: Connecting in vivo neuroplastogen responses with mechanistic screening in primary cortical neurons and human iPSC-derived neurons across molecular, structural and functional endpoints.

Speakers:

Head of preclinical neuropharmacology
Ulysses Neuroscience
Head of Translational Medicine
Ulysses Neuroscience